SUBJECT INDEX 



415 



Infections 



bacterial, cultured cells and, 72 

 initiation and, 15-18 

 rickettsial, cultured cells and, 72 

 viral, mitosis and, 68 

 Influenza A virus, 126-127, 200, 201, 254- 

 265 

 age distribution and, 261-263 

 a-amino-p-methoxyphenylmethane- 

 sulfonic acid, release inhibition and, 

 217 

 cellular receptors and, 51 

 8 forms and, 25 

 D phase and, 25, 231-232 

 5, 6-dichloro-l-/J-D-ribofuranosylbenl- 



zimidazole and, 208 

 2, 5-dimethylbenzimidazole and, 205 

 hemagglutination and, 23, 25, 26, 230 

 host-induced variation and, 229 

 influenza B virus, pure clone isolations 



and, 278 

 levo-y-(o-chlorobenzyl)-S-oxoy-phenyl- 



caproic acid and, 203, 210, 213 

 DL-methoxinine and, 203, 205-206, 212, 



213, 217 

 O phase and, 25, 231-232 

 ovomucin hemagglutination inhibition 



and, 53 

 w forms and, 

 Influenza A virus Alabama, 258 

 Influenza A virus Asian, 263, 264 

 Influenza A virus BEL 

 Chu inhibitor and, 35 

 receptor gradient and, 29 

 stabilized cells, electrophoretic mobility 

 and, 30 

 Influenza A virus BEL D, Chu inhibitor 



and, 35 

 Influenza A virus CAM, 159, 173, 256, 266 

 influenza A virus WSE, linkage group 



interchange and, 285 

 mouse lung virulence redistribution and, 

 291,292 

 Influenza A virus FMI, 173, 208, 256, 257, 



258, 264 

 Lifluenza A virus Hume, 257 

 Influenza A virus KUNZ, neuropatho- 



genicity transfer and, 290 

 Influenza A virus MEL, 173, 174, 175, 176, 

 177, 258, 260 



hemagglutination and, 26 



indicator virus and, 34 



influenza A virus NWSE, heterozygosis 



and, 287 

 influenza A virus WSE 



genetic interaction and, 283, 284-285 



linkage group interchange and, 285 



phenotypic mixture and, 286, 294-295 

 influenza A virus WSN 



heterozygosis and, 287-288 



phenotypic mixture and, 286-287 

 mouse lung virulence redistribution and, 



291, 292 

 mucoid inhibitor and, 37 

 neuropathogenicity transfer and, 290 

 receptor gradient and, 29 

 stabilized cells, electrophoretic mobility 



and, 30 

 Influenza A virus NWS, 17, 175 



influenza virus SW, genetic interaction 



and, 282-283 

 Influence A virus NWSE 



influenza A virus MEL, heterozygosis 



and, 287 

 Influenza A virus Oc.I, neuropathogenicity 



transfer and, 290 

 Influence A virus PER, mouse lung 



virulence redistribution and, 291-292 

 Influenza A virus PR8, 174, 177, 184, 208, 



255, 256, 257, 258, 259, 260, 261, 262, 

 264, 266, 267 



bovine submaxillary gland mucoprotein 



and, 56 

 fluorescent antibody studies and, 88 

 hemagglutination and, 24, 26, 27 

 hemagglutinin of, 130 

 indicator virus, 34 mucoid inhibitor and, 



37 

 stabilized cells, electrophoretic mobility 

 and, 30 

 Influenza A virus SW, influenza virus 

 NWS, genetic interaction and, 282-283 

 Influenza A virus Talmey, 258 

 Influenza A virus WS, 167, 173, 177, 255, 



256, 257, 258, 259, 260, 261, 284 

 bronchial epithelial cells 



deoxyribonucleic acid and, 86-87 



glycoprotein and, 86 

 genetic interaction and, 283 

 hemagglutination and, 25, 26 



